Therapy: Liraglutide - preventing or postponing T2DM diagnosis?
- PMID: 28474687
- DOI: 10.1038/nrendo.2017.55
Therapy: Liraglutide - preventing or postponing T2DM diagnosis?
Comment on
-
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.Lancet. 2017 Apr 8;389(10077):1399-1409. doi: 10.1016/S0140-6736(17)30069-7. Epub 2017 Feb 23. Lancet. 2017. PMID: 28237263 Clinical Trial.
Similar articles
-
[Effect of liraglutide on glucagon secretion in obese type 2 diabetic patients].Zhonghua Nei Ke Za Zhi. 2019 Jan 1;58(1):33-38. doi: 10.3760/cma.j.issn.0578-1426.2019.01.006. Zhonghua Nei Ke Za Zhi. 2019. PMID: 30605948 Chinese.
-
[The efficacy and safety of human glucagon-like peptide-1 analogue liraglutide in newly diagnosed type 2 diabetes with glycosylated hemoglobin A1c > 9].Zhonghua Nei Ke Za Zhi. 2015 Apr;54(4):307-12. Zhonghua Nei Ke Za Zhi. 2015. PMID: 26268058 Clinical Trial. Chinese.
-
[Prognostic factors for the carbohydrate metabolism normalization in patients with type 2 diabetes mellitus and obesity using liraglutide 3.0 mg per day].Ter Arkh. 2021 Oct 15;93(10):1203-1208. doi: 10.26442/00403660.2021.10.201070. Ter Arkh. 2021. PMID: 36286822 Russian.
-
[Weight reducing and glucose reducing effects of liraglutide treatment for patients with type 2 diabetes].Ugeskr Laeger. 2011 Jun 27;173(26):1863-9. Ugeskr Laeger. 2011. PMID: 21712007 Review. Danish.
-
Liraglutide for type 2 diabetes mellitus.Expert Opin Biol Ther. 2011 Jul;11(7):951-9. doi: 10.1517/14712598.2011.583641. Epub 2011 May 12. Expert Opin Biol Ther. 2011. PMID: 21563859 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical